Progress in L2-Based Prophylactic Vaccine Development for Protection against Diverse Human Papillomavirus Genotypes and Associated Diseases

por Olczak, Pola, Roden, Richard B.S.
Publicado 2020

Opportunities to improve immune-based prevention of HPV-associated cancers

por Stern, Peter L., Roden, Richard BS.
Publicado 2019

Capsid display of a conserved human papillomavirus L2 peptide in the adenovirus 5 hexon protein: a candidate prophylactic hpv vaccine approach

por Wu, Wai-Hong, Alkutkar, Tanwee, Karanam, Balasubramanyan, Roden, Richard BS, Ketner, Gary, Ibeanu, Okechukwu A.
Publicado 2015

Co-administration with DNA encoding papillomavirus capsid proteins enhances the antitumor effects generated by therapeutic HPV DNA vaccination

por Yang, Benjamin, Yang, Andrew, Peng, Shiwen, Pang, Xiaowu, Roden, Richard B.S., Wu, T.-C., Hung, Chien-Fu
Publicado 2015

Safety Run-in of Intramuscular pNGVL4a-Sig/E7(detox)/HSP70 DNA and TA-CIN Protein Vaccination as Treatment for HPV16+ ASC-US, ASC-H, or LSIL/CIN1

por Einstein, Mark H., Roden, Richard B.S., Ferrall, Louise, Akin, Mark, Blomer, Allison, Wu, T.C., Chang, Yung-Nien
Publicado 2023

Efficacy of RG1-VLP Vaccination against Infections with Genital and Cutaneous Human Papillomaviruses

por Schellenbacher, Christina, Kwak, Kihyuck, Fink, Dieter, Shafti-Keramat, Saeed, Huber, Bettina, Jindra, Christoph, Faust, Helena, Dillner, Joakim, Roden, Richard B.S., Kirnbauer, Reinhard
Publicado 2013

RPN13/ADRM1 inhibitor reverses immunosuppression by myeloid-derived suppressor cells

por Soong, Ruey-Shyang, Anchoori, Ravi K., Yang, Benjamin, Yang, Andrew, Tseng, Ssu-Hsueh, He, Liangmei, Tsai, Ya-Chea, Roden, Richard B.S., Hung, Chien-Fu
Publicado 2016

Control of HPV-associated tumors by innovative therapeutic HPV DNA vaccine in the absence of CD4+ T cells

por Peng, Shiwen, Song, Liwen, Knoff, Jayne, Wang, Joshua W, Chang, Yung-Nien, Hannaman, Drew, Wu, T-C, Alvarez, Ronald D, Roden, Richard BS, Hung, Chien-Fu
Publicado 2014

Incorporation of RG1 epitope concatemers into a self-adjuvanting Flagellin-L2 vaccine broaden durable protection against cutaneous challenge with diverse human papillomavirus genot...

por Kalnin, Kirill, Chivukula, Sudha, Tibbitts, Timothy, Yan, Yanhua, Stegalkina, Svetlana, Shen, Lihua, Cieszynski, Jacqueline, Costa, Victor, Sabharwal, Robert, Anderson, Stephen F., Christensen, Neil, Jagu, Subhashini, Roden, Richard B.S., Kleanthous, Harry
Publicado 2017

In vivo characterization of emerging SARS-CoV-2 variant infectivity and human antibody escape potential

por Lam, Brandon, Kung, Yu Jui, Lin, John, Tseng, Ssu-Hsueh, Tsai, Ya Chea, He, Liangmei, Castiglione, Gianni, Egbert, Emily, Duh, Elia J., Bloch, Evan M., Tobian, Aaron A.R., Milstone, Aaron M., Roden, Richard B.S., Wu, Tzyy-Choou, Hung, Chien-Fu
Publicado 2021

Meeting Report: Translational Advances in Cancer Prevention Agent Development Meeting

por Miller, Mark Steven, Allen, Peter J., Brown, Powel H., Chan, Andrew T., Clapper, Margie L., Dashwood, Roderick H., Demehri, Shadmehr, Disis, Mary L., DuBois, Raymond N., Glynn, Robert J., Kensler, Thomas W., Khan, Seema A., Johnson, Bryon D., Liby, Karen T., Lipkin, Steven M., Mallery, Susan R., Meuillet, Emmanuelle J., Roden, Richard B.S., Schoen, Robert E., Sharp, Zelton D., Shirwan, Haval, Siegfried, Jill M., Rao, Chinthalapally V., You, Ming, Vilar, Eduardo, Szabo, Eva, Mohammed, Altaf
Publicado 2021